Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-001158

Chief Business Officer sold 6,945 shares at $26.32 ($182,795)

  • Chief Business Officer acquired 6,945 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Parrish Jay · Chief Business Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-04 Exercise or conversion : show line 1 in the form +6,945 $1.49 $10,313 229,167 D
2021-01-04 Sale : show line 2 in the form −6,945 $26.32 $182,795 222,222 D
Open-market sales · 6,945 sh · avg $26.32 · $182,795

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-01 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −6,945 16,203 D
Loading xslF345X03/doc4.xml…